News

Amrize Delivers Solid Second Quarter, Starts Journey in Position of Strength
Successful spin-off and listing of Amrize on the NYSE and SIX on June 23. Resilient Q2 results with strong margins show ...
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Zomedica posts record year-over-year revenue for 18th straight quarter! ANN ARBOR, MI / ACCESS Newswire / August 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary ...